These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 36337685)

  • 1. SARS-CoV-2 Omicron (BA.1 and BA.2) specific novel CD8+ and CD4+ T cell epitopes targeting spike protein.
    Parn S; Savsani K; Dakshanamurthy S
    Immunoinformatics (Amst); 2022 Dec; 8():100020. PubMed ID: 36337685
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SARS-CoV-2 Omicron BA.4/BA.5 Mutations in Spike Leading to T Cell Escape in Recently Vaccinated Individuals.
    Emmelot ME; Vos M; Boer MC; Rots NY; van Els CACM; Kaaijk P
    Viruses; 2022 Dec; 15(1):. PubMed ID: 36680141
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A bioinformatic analysis of T-cell epitope diversity in SARS-CoV-2 variants: association with COVID-19 clinical severity in the United States population.
    Kim GJ; Elnaggar JH; Varnado M; Feehan AK; Tauzier D; Rose R; Lamers SL; Sevalia M; Nicholas N; Gravois E; Fort D; Crabtree JS; Miele L
    Front Immunol; 2024; 15():1357731. PubMed ID: 38784379
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of SARS-CoV-2 Omicron BA.1 Spike Mutations on T-Cell Epitopes in Mice.
    Wang Y; Wang B; Zhao Z; Xu J; Zhang Z; Zhang J; Chen Y; Song X; Zheng W; Hou L; Wu S; Chen W
    Viruses; 2023 Mar; 15(3):. PubMed ID: 36992472
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunoinformatics and MD-simulation data suggest that Omicron spike epitopes are more interacting to IgG via better MHC recognition than Delta variant.
    Sarkar A; Santra D; Sundar Panja A; Maiti S
    Int Immunopharmacol; 2023 Oct; 123():110636. PubMed ID: 37499394
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunoinformatic approach for the construction of multi-epitopes vaccine against omicron COVID-19 variant.
    Khan K; Khan SA; Jalal K; Ul-Haq Z; Uddin R
    Virology; 2022 Jul; 572():28-43. PubMed ID: 35576833
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Omicron BA.1 Mutations in SARS-CoV-2 Spike Lead to Reduced T-Cell Response in Vaccinated and Convalescent Individuals.
    Emmelot ME; Vos M; Boer MC; Rots NY; de Wit J; van Els CACM; Kaaijk P
    Viruses; 2022 Jul; 14(7):. PubMed ID: 35891550
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutations in spike protein T cell epitopes of SARS-COV-2 variants: Plausible influence on vaccine efficacy.
    Sankaranarayanan S; Mohkhedkar M; Janakiraman V
    Biochim Biophys Acta Mol Basis Dis; 2022 Sep; 1868(9):166432. PubMed ID: 35568352
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Resilience of Spike-Specific Immunity Induced by COVID-19 Vaccines against SARS-CoV-2 Variants.
    Ballesteros-Sanabria L; Pelaez-Prestel HF; Ras-Carmona A; Reche PA
    Biomedicines; 2022 Apr; 10(5):. PubMed ID: 35625733
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Minimal Crossover between Mutations Associated with Omicron Variant of SARS-CoV-2 and CD8
    Redd AD; Nardin A; Kared H; Bloch EM; Abel B; Pekosz A; Laeyendecker O; Fehlings M; Quinn TC; Tobian AAR
    mBio; 2022 Apr; 13(2):e0361721. PubMed ID: 35229637
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In silico SARS-CoV-2 vaccine development for Omicron strain using reverse vaccinology.
    Li V; Lee C; Yoo D; Cho S; Kim H
    Genes Genomics; 2022 Aug; 44(8):937-944. PubMed ID: 35665465
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Synthetic SARS-CoV-2-Derived T-Cell and B-Cell Peptide Cocktail Elicits Full Protection against Lethal Omicron BA.1 Infection in H11-K18-hACE2 Mice.
    Song Y; Hu H; Xiao K; Huang X; Guo H; Shi Y; Zhao J; Zhu S; Ji T; Xia B; Jiang J; Cao L; Zhang Y; Zhang Y; Xu W
    Microbiol Spectr; 2023 Mar; 11(2):e0419422. PubMed ID: 36912685
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential epitope prediction across diverse circulating variants of SARS-COV-2 in Brazil.
    Cavalcanti-Dantas VM; Fernandes B; Dantas PHLF; Uchoa GR; Mendes AF; Araújo Júnior WO; Castellano LRC; Fernandes AIV; Goulart LR; Oliveira RADS; Assis PAC; Souza JR; Morais CNL
    Comput Biol Chem; 2024 Jun; 112():108139. PubMed ID: 38972100
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Peptide Vaccine Design Targeting KIT Mutations in Acute Myeloid Leukemia.
    Kim M; Savsani K; Dakshanamurthy S
    Pharmaceuticals (Basel); 2023 Jun; 16(7):. PubMed ID: 37513844
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Glycosylated RBD Protein Induces Enhanced Neutralizing Antibodies against Omicron and Other Variants with Improved Protection against SARS-CoV-2 Infection.
    Shi J; Zheng J; Tai W; Verma AK; Zhang X; Geng Q; Wang G; Guan X; Malisheni MM; Odle AE; Zhang W; Li F; Perlman S; Du L
    J Virol; 2022 Sep; 96(17):e0011822. PubMed ID: 35972290
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Computational perspectives revealed prospective vaccine candidates from five structural proteins of novel SARS corona virus 2019 (SARS-CoV-2).
    Anand R; Biswal S; Bhatt R; Tiwary BN
    PeerJ; 2020; 8():e9855. PubMed ID: 33062414
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Minimal cross-over between mutations associated with Omicron variant of SARS-CoV-2 and CD8+ T cell epitopes identified in COVID-19 convalescent individuals.
    Redd AD; Nardin A; Kared H; Bloch EM; Abel B; Pekosz A; Laeyendecker O; Fehlings M; Quinn TC; Tobian AA
    bioRxiv; 2021 Dec; ():. PubMed ID: 34909772
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An immunoinformatics study on the spike protein of SARS-CoV-2 revealing potential epitopes as vaccine candidates.
    Ashik AI; Hasan M; Tasnim AT; Chowdhury MB; Hossain T; Ahmed S
    Heliyon; 2020 Sep; 6(9):e04865. PubMed ID: 32923731
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunoinformatics approach of epitope prediction for SARS-CoV-2.
    Awad N; Mohamed RH; Ghoneim NI; Elmehrath AO; El-Badri N
    J Genet Eng Biotechnol; 2022 Apr; 20(1):60. PubMed ID: 35441904
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SARS-CoV-2 Omicron BA.1 variant breakthrough infections in nursing home residents after an homologous third dose of the Comirnaty® COVID-19 vaccine: Looking for correlates of protection.
    Torres I; Giménez E; Albert E; Zulaica J; Álvarez-Rodríguez B; Burgos JS; Peiró S; Limón R; Vanaclocha H; Rodado C; Botija P; Sifre A; Tur B; Lozano RA; Orosa I; Vicente-Ruiz M; Carrión RJ; Clari MÁ; Sánchez-Payá J; Díez-Domingo J; Comas I; González-Candelas F; Geller R; Navarro D;
    J Med Virol; 2022 Sep; 94(9):4216-4223. PubMed ID: 35585782
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.